Related Experiment Video
Updated: Jul 10, 2026
11:31
Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
Published on: July 4, 2018
Pathogenic role of CCL2/MCP-1 in scleroderma
1Department of Dermatology, Fukushima Medical University, Fukushima, Japan. toyamade@fmu.ac.jp
Frontiers in Bioscience : a Journal and Virtual Library
|November 6, 2007
Summary
Scleroderma involves excessive skin matrix deposition. This review explores how CCL2 (monocyte chemoattractant protein-1) and its receptor mediate inflammation and fibrosis in scleroderma.
Area of Science:
- Immunodermatology
- Connective Tissue Diseases
- Fibrosis Research
Background:
- Scleroderma is a connective tissue disease marked by excessive extracellular matrix deposition in the skin.
- Immune cell infiltrates and inflammatory mediators are implicated in the pathogenesis of cutaneous fibrosis.
- Leukocyte trafficking, crucial for inflammation, is regulated by adhesion molecules and chemokines.
Purpose of the Study:
- To review the role of CCL2 (monocyte chemoattractant protein-1) and its receptor in scleroderma.
- To elucidate the mechanisms of inflammation and fibrosis in scleroderma.
- To provide current insights into scleroderma pathogenesis.
Main Methods:
- Literature review focusing on chemokine roles in scleroderma.
- Analysis of studies investigating CCL2 and its receptor in cutaneous fibrosis.
- Synthesis of current understanding of immune cell involvement.
Main Results:
- Increased proinflammatory chemokines are linked to fibrotic conditions.
- CCL2/monocyte chemoattractant protein-1 is a key chemokine implicated in scleroderma.
- Complex interactions between fibroblasts and immune cells contribute to fibrosis.
Conclusions:
- CCL2 and its receptor are significant mediators of inflammation and fibrosis in scleroderma.
- Understanding these pathways offers potential therapeutic targets for scleroderma.
- Further research into chemokine networks is vital for unraveling scleroderma mechanisms.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...